Neoadjuvant therapy of high-risk gastric cancer: A phase II trial of preoperative FAMTX and postoperative intraperitoneal fluorouracil-cisplatin plus intravenous fluorouracil

D. Kelsen, M. Karpeh, G. Schwartz, H. Gerdes, C. Lightdale, J. Botet, G. Lauers, D. Klimstra, Y. Huang, L. Saltz, V. Quan, M. Brennan

Research output: Contribution to journalArticlepeer-review

116 Scopus citations

Fingerprint

Dive into the research topics of 'Neoadjuvant therapy of high-risk gastric cancer: A phase II trial of preoperative FAMTX and postoperative intraperitoneal fluorouracil-cisplatin plus intravenous fluorouracil'. Together they form a unique fingerprint.

Medicine & Life Sciences